节点文献

华蟾素注射液多肽成分体外抗肿瘤活性研究

In vitro anti-proliferation effect of peptides from cinobufacini injection

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴旭高波杨健边宝林王宏洁

【Author】 WU Xu1,GAO Bo2,YANG Jian1,BIAN Bao-lin1,WANG Hong-jie1(1.Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China; 2.Anhui Jinchan Biochemistry Company Ltd.,Huaibei 235000,China)

【机构】 中国中医科学院中药研究所安徽金蟾生化股份有限公司

【摘要】 <正>华蟾素是从中华大蟾蜍Bufo bufo gargarizansCantor的干燥皮提取精制而成的水溶性制剂,已列为国家中药保护品种。其注射液是应用较早的剂型之一,目前广泛应用于多种中晚期肿瘤,如原发性肝癌、胃癌、肺癌、结肠癌、胰腺癌等[1?3]。大量的临床与实验研究证实华蟾素注射液是安全、有效的抗

【Abstract】 Cinobufacini is an aqueous extract of Bufo bufo gargarizans Cantor dried skin,which has been widely used for cancer therapy in China.So far,its active components are still not very clear.In previous reports,bufadienolides with low-concentration were usually studied because of their anticancer effects.However,the high polarity constituents in cinobufacini are less investigated.The present study found that more than 50% contents of cinobufacini were water-soluble peptides.Then,in vitro anticancer experiments were carried out,including human stomach cancer cell lines BGC823 and MCG803,human colon cancer cell lines DLD-1 and HT-29,and human pancreatic cancer cell line MIAPACA-2.The IC50 for these cell lines model were ranged from 25-123 -g·mL/1.The results indicated that these peptides showed similar activity with cinobufacini injection.As a conclusion,this study provides a new and further understanding of anticancer components in cinobufacini injection.

【基金】 中国中医科学院自选课题资助项目(z02063)
  • 【文献出处】 药学学报 ,Acta Pharmaceutica Sinica , 编辑部邮箱 ,2012年06期
  • 【分类号】R96
  • 【被引频次】41
  • 【下载频次】743
节点文献中: 

本文链接的文献网络图示:

本文的引文网络